98Q-15280-79952
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 234 / VA
- Registered
- 2021-08-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
9W2-97642-09617
Child or adolescent in my care · Female · 2022-02-10
6WE-20767-87734
Child or adolescent in my care · Male · 2022-02-10
Timeline
-
2021-08-17
Registered in v-safe
-
2021-08-17
Dose 1 — Pfizer-BioNTech
- 2021-08-17
- 2021-08-18
- 2021-08-19
-
2021-08-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-08-21
- 2021-08-22
-
2021-08-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-08-24
- 2021-08-31
- 2021-09-07
-
2021-09-10
Dose 2 — Pfizer-BioNTech
- 2021-09-14
- 2021-09-15
- 2021-09-17
-
2021-09-24
Survey response — day 14, dose 2MedDRA: Migraine — Feeling: FairFree text: Daily migrainesMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2022-02-09
Dose 3 — Pfizer-BioNTech
- 2022-02-12
- 2023-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-17 | Pfizer-BioNTech | No |
| 2 | 2021-09-10 | Pfizer-BioNTech | No |
| 3 | 2022-02-09 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Daily migraines
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Migraine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release